Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Focao Yishen tea is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Shanghai Municipal Hospital of Traditional Chinese Medicine and Shanghai University of TCM. It is primarily investigated for the treatment of subthreshold depression, a condition characterized by depressive symptoms that do not meet the full diagnostic criteria for major depressive disorder. In TCM theory, the formulation likely aims to tonify the kidney (Yishen) to address the underlying imbalances associated with mood disorders. It is administered as a tea and has been evaluated in Phase 0 clinical trials in China to assess its efficacy and safety compared to low-dose controls.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Focao Yishen tea.